Regencell Bioscience's total assets for Q2 2025 were $7.48M, a decrease of -11.37% from the previous quarter. RGC total liabilities were $763.84K for the fiscal quarter, a 247.97% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.